Newswise — Ankeny, IA – June 24, 2026 — Proliant Health & Biologicals, a global leader in purified proteins, today announced the commercial launch of AlbufreeDX, a recombinant human albumin (rHA) designed to meet the growing demand for high-performance, animal-free ingredients across diagnostic and life science applications. For more than two decades, Proliant has been a trusted manufacturer of albumin and other purified proteins, delivering consistent quality and dependable supply worldwide. Headquartered in Ankeny, Iowa, with manufacturing locations in the United States and New Zealand, Proliant continues to expand its capabilities to support biotechnology, diagnostics, and healthcare markets. Albumin is widely used in diagnostics, biopharmaceutical manufacturing, and research workflows for its ability to stabilize proteins, prevent undesirable surface binding, and improve assay performance and reproducibility. “AlbufreeDX is a natural extension of our strengths—offering an animal-free albumin option while maintaining the consistency, reliability, and scale our customers expect.”